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      Skeletal muscle is a highly differentiated tissue with very specific functions which has low potential of 
regeneration. Skeletal muscle injuries especially in athletes almost have lead to muscular dysfunctions and 
healing may be prolonged for several years. Therefore, working on skeletal muscle differentiation remained an 
importance in biomedical researches. Adipose derived stem cells (ADSCs) are novel source of mesenchymal 
stem cells which are an excellent alternative for satellite cells in in-vitro skeletal muscle differentiation. 
Differentiation potential of ADSCs on both tissue culture plate (TCP) and also on Poly l-lactide acid (PLLA) 
electrospun fibrous nano-scaffold which now is widely used at tissue engineering investigations has studied in 
this research. Scanning electron microscopy (SEM) and Tensile test were performed for evaluating scaffold 
properties. Hydrocortisone has considered a critical factors for skeletal muscle differentiation while, the 
recommended concentrations of it for inducing myogenesis in stem cells is yet discussing. Statistical analysis 
of our results from colorimetric MTT assay for various concentrations of hydrocortisone showed that the 
concentration of 10
-7
 mol/L is the optimum dose for myogenic differentiation of murine ADSCs which was 
used on both TCP and PLLA scaffolds and skeletal myosin fiber formations was confirmed with 
immunocytochemistry. DAPI staining proved myocytes nuclei and syncytium formations. Our results also 
showed that ADSCs and PLLA nano-scaffolds are the suitable biomaterials for engineering skeletal muscle 
tissue.      
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INTRODUCTION 
      Highly differentiated skeletal muscle cells with 
distinguished functional specification have low 
potential for proliferation and regeneration. 
Therefore, pleasant healing of damaged or 
defective tissue has been a therapeutic problem [1, 
2]. Two main obstacles of stem cell therapy are 
finding suitable stem cell source and efficient 
transplantation mechanisms, which are more 
complicated in case of skeletal muscle tissue. 
Mesenchymal adipose-derived stem cells (ADSCs) 
are privileged alternative for low number and 
unattainable muscle stem/progenitor cells 
especially in in-vitro culture systems [3].  
ADSCs are highly proliferative and can be 
adequately obtained by noninvasive surgery. 
Excellent differentiation potential of these cells to 
various tissues and their immunemodulatory 
features have demonstrated in recent published 
works [4, 5].  Hydrocortisone mentioned as critical 
factor of skeletal muscle differentiation in most 
articles [6, 7] while the suitable concentration of it 
is not scientifically determined yet. Hydrocortisone 
concentration mentioned to make various 
responses in different cell types and can cause 
growth inhibition and aging at in vitro cell cultures 
[8, 9].  
Therefore, determination an optimum 
concentration of it for skeletal muscle 
differentiation should be well investigated.    
Poly L-Lactide Acid (PLLA) is a biodegradable 
and biocompatible polymer that breaks down to 
safe material of lactic acid. PLLA nanofibers that 
now are widely using in tissue engineering can be 
easily obtained by electrospining method of 
scaffold fabrication [10-12].   
 




In this study we tried to differentiate murine 
ADSCs to skeletal muscle cells by various 
concentrations of hydrocortisone and then the cells 
viability, proliferation and differentiation was 
examined on PLLA fibrous scaffold.        
 
MATERIALS AND METHODS 
Electrospining and Mechanical properties of the 
PLLA Scaffold 
     As it previously described for PLLA 
electrospining method [13-15], the polymer of 
poly l-lactide acid (Sigma-Aldrich, St. Louis, 
http://www.sigmaaldrich.com) with MW of 
240,000 g/mol was dissolved in chloroform 
(Merck, Germany) and dimethylformamaide 
(Sigma-Aldrich, St. Louis, 
http://www.sigmaaldrich.com) (4.25:0.75) and was 
remained on stirrer for about 3h. 
 The obtained material was loaded to plastic 
syringes with 21-gauge needle that was placed at 
15 cm from collector which was set to rotate with 
2300 rpm. Nanofibers were collected by applying 
positive voltage of 18 KV between needle and 
collector. Oxygen plasma surface modification 
performed for 5 min by frequency plasma 
generator (Diener Electronics, Germany) to make 
the scaffold hydrophilic. Before cell seeding, the 
scaffolds were sterilized by ethanol 70%. Tensile 
tester (SANTAM stress machine, Iran) at speed 
rate of 50 mm/min was utilized to examine 
mechanical aspects of fibrous PLLA scaffold 
pieces that were cut in 60×10 mm
2
 rectangular.  
Scanning Electron Microscopy (SEM) 
    The PLLA electrospun nanofibrous scaffolds 
simply were gold sputtered in vacuum and 
AIS2300C scanning electron microscope 
(SERON, Korea) was used for imaging.  
 
Cell Culture 
     Murine ADSCs at first passage were purchased 
from Stem Cell Technology Research Center 
(Tehran, Iran) and were expanded. Second passage 
cells were cultured in 24 well plates in Dulbecco’s 
Modified Eagle’s Medium (DMEM) 
supplemented with 10% Fetal Bovine Serum 
(FBS), 100 µg/ml penicillin and 100 µg/ml 
streptomycin (all from Gibco, USA) to reach 90% 
confluency. The plates were incubated in humid 
incubator at 37°C and 5% CO2. Then, myogenic 
differentiation medium contained DMEM 
supplemented with 10% FBS, 10% horse serum 














 (mol/L).  The ADSCs were also cultured on 
O2 plasma treated and sterilized PLLA scaffolds 
which were punched to fix in 24 well cell culture 
plates at the density of 1×10
4
 per well. After 24h 
(for allowing cells to adhere), ADSCs were 
differentiated using 1×10
-7
 concentration of 




    To study the effect of hydrocortisone 
concentrations on the cells viability colorimetric 
assay was performed. Mitochondrial activity of 
viable cells was measured by 3-(4,5-
dimethythiazol-2-yl) 2,5diphenyl tetrazolium 
bromide (MTT) assay.  
The blue crystals of formazan were dissolved in 
dimethyl sulfoxide (DMSO) and the optical 
density of solution read at 570 nm using 
BioPhotometer (Eppendorf, Germany). The test 
was performed at 2 and 4 days after applying 
differentiation medium. After determination of 
best hydrocortisone concentration, MTT assay was 
also performed for ADSCs were cultured on PLLA 
scaffold in comparison with tissue culture plates 
during 5 days with and without applying myogenic 
differentiation medium.  
 
Immunocytochemistry 
     The expression of myosin at the differentiated 
cells on PLLA scaffolds and normal culture was 
investigated by applying a routine protocol of 
Immunocytochemistry.  
The Monoclonal anti-myosin (skeletal, slow) 
Mouse Ascites Fluid (Sigma-Aldrich, St. Louis, 
http://www.sigmaaldrich.com); (2:1000) and 
Goat F antimouse IgG (PE) (Cedarlane, Hornby, 
Ontario, Canada); (2:1000) were used as the first 
and secondary antibodies, respectively. DAPI 
(4',6-diamidino-2-phenylindole) staining was 
done for nuclear staining. Fluorescence was 
analyzed using an inverted fluorescence 
microscope (Nikon TE-2000, Japan). 
 
Statistics 
     Two-way analysis of variance (ANOVA) and 
bonferroni post-test were used for statistical 
analysis of quantitative results that were 
expressed as mean ± standard deviation (SD) 
and P<0.05 considered statistically significant.    
 





Scanning Electron Microscopy  
    The SEM images indicate the obtained random 
PLLA fibrous scaffold using electrospining 




Figure 1. SEM image of PLLA nanofibrous scaffold 
fabricated by electrospining method. The scale bar is 10 µm.    
 
Mechanical Properties of PLLA Scaffold   
    Stress-strain curve indicates plasticity and 
mechanical properties of the scaffold which 
provided proper aspects for skeletal muscle tissue 
engineering (Figure 2). 
Cells Proliferation and Viability  
    Figure 3A shows the statistical analysis of MTT 
results which compares viability of murine ADSCs 
treated by myogenic differentiation with various 
concentrations of hydrocortisone at day 2 and day 
4.  Graphs indicates the amounts of cells viability 
at the hydrocortisone concentrations less than 10
-7 
mol/L was much lower than 50% amount of cells 
viability at the concentration of 0. Figure 4c 
displays cell death that occurred by using 
concentration of 1×10
-6
 mol/L hydrocortisone in 
the differentiation medium at day 5 while the 
concentration of 1×10
-7
 has induced differentiation 
without decreasing the cells number in comparison 
with control (Figure 4a and b). Even without 
staining the aggregations of the nuclei at the 






However there was no significant (P>0.05) 





 mol/L, but the cells 
viability was higher at the day 4 versus day 2 at 
the concentration of 1×10
-8
 mol/L. Reversely, 
the cells were still proliferative at 1×10
-6
 mol/L. 
Also, the results indicated that the proliferation 
of the cells at the concentration of 1×10
-9
 did not 
much differ from culture without hydrocortisone 
(concentration of 0) at the both time points. 
Interestingly, it seems that cells proliferation has 
stopped at the concentration of 1×10
-7 
mol/L 
considering this dose was not lethal (the cells 
viability was more than 50%).   
MTT assay also performed to compare cells 
proliferation and viability between normal 
(TCP) and 3D cultures (Figure 3B). Statistically 
analyzed data showed that the cells proliferation 
and viability was significantly (P<0.05) higher 
at the 3D culture against TCP after 4 days. In 
case of myogenic medium that the cells were at 
90% confluency at day 0, it seems that however 
the viability of cells was significantly (P<0.05) 
higher at 3D culture but the viability amount 
was remained almost constant at both TCP and 




Figure 2. Stress-strain curve of PLLA nanoscaffold.  
 
 






Figure 3. Statistical analysis of MTT results; (A): 
comparing various concentrations of hydrocortisone at the 
myogenic medium on ADSCs at day 2 and 4. (B): 
comparing the ADSCs proliferation between TCP and on 
PLLA scaffolds during 5 days. (C): comparing cells 
viability among TCP cultures and on PLLA scaffolds 
during 5 days of applying myogenic medium (the TCP 
control stands for cells on normal culture medium); the 
cells were at the 90% confluency before treating. N=3, 





Figure 4. Shows the ADSCs cultured in normal culture 
medium (a) and in skeletal cells differentiation medium 
with concentrations of 10-7 (b) and 10-6 (c) mol/L of 
hydrocortisone at day 5 post-differentiation. 4X. Arrows 
indicate aggregations of nuclei at myocytes.  
 
 




Cell differentiation  
     The formation of myosin fibers at the 
differentiated myocytes and myotubes is showed 
by immunofluorescent staining at the normal and 
3D cultures on PLLA nanofibers. Nuclear staining 
by DAPI represented the cells and Syncytium 





Figure 5. Immunocytochemistry of differentiated skeletal 
myocytes at 3D culture on PLLA scaffold (a, a’) and TCP 
culture (b, b’). Nuclei were stained DAPI (a and b) and the 
myosin fibers formation (a’ and b’) in differentiated murine 
ADSCs are shown.  
 
DISCUSSION 
     Fibrous structure of PLLA scaffold as it showed 
by SEM images can provide better environment 
for cells to nourish, growth and proliferate. 
Statistical analysis of MTT results represented that 
after 3 days of the culture the proliferation and 
viability of ADSCs were significantly (P<0.05) 
increased on 3D culture compare to TCP. The 
PLLA polymers are also biocompatible and did 
not affect cells growth; the proliferation of ADSCs 
significantly (P<0.05) increased on PLLA scaffold 
after 4 days of culture. Therefore, as it previously 
described in authors reports, PLLA has remarkably 
improved the quality of the cell’s environment [14, 
16-18]. Results of tensile test also has indicated 
that the scaffold has suitable mechanical properties 
and plasticity for skeletal muscle differentiation as 
it mentioned by researchers [19, 20]. There is a 
lack of determining the exact concentration of 
hydrocortisone which induces skeletal muscle 
differentiation in mesenchymal stem cells. 
Different studies have suggested various 
concentration of hydrocortisone to use in skeletal 
muscle differentiation medium; a range of 18 
mg/mL [21], 0.2 μM [22], 50 μM hydrocortisone 
[23, 24] and even 2% [25] to 5% hydrocortisone 
[26] have been noted. While, the statistical analysis 
of our MTT results from various hydrocortisone 
concentrations in TCP cultures demonstrated that 
concentration of 1×10
-7
 mol/L is suitable dose for 
inducing skeletal muscle differentiation which 
stops the cells proliferation and is not toxic while 







mol/L seems to be more lethal for 
mesenchymal stem cells than inducing 
differentiation; at those concentrations of 
hydrocortisone the rate of cell death is more than 
50% in comparison with medium free from 





mol/L did not fully stop the cells proliferation and 
did not much differ from control group (medium 
without hydrocortisone). Analysis of MTT results 
from 3D and TCP cultures by applying myogenic 
differentiation with concentration of 10
-7
 mol/L of 
hydrocortisone also illustrated that scaffold did not 
interfered or affected skeletal muscle 
differentiation as it confirmed by ICC results that 
has stained the myosin fibers which were well 
generated at both culture types.  
Consequently, ADSCs and PLLA nanoscaffold are 
the correct biomaterials for skeletal muscle tissue 
engineering and the concentration of 10
-7
 mol/L of 
hydrocortisone is suggested as the optimum dose 
for skeletal muscle differentiation of murine 
ADSCs. Myogenic differentiation protocols and 
techniques yet need to be improved by further 
researches.      
 
CONCLUSION 
      In this study we compared various 
concentrations of hydrocortisone for inducing 
myogenic differentiation and the concentration of 
10
-7
 mol/L was selected to be the most suitable 
dose for skeletal muscle differentiation of murine 
ADSCs. The PLLA nanofiber electrospun scaffold 
also introduced to has excellent performance for 
supporting myogenic differentiation of stem 
cells.     
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